Literature DB >> 15306091

Rate control in atrial fibrillation: what approach is best?

Brian Olshansky.   

Abstract

Entities:  

Year:  2004        PMID： 15306091     DOI： 10.1007/s11886-004-0037-4

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN： 1523-3782            Impact factor:   2.931


× No keyword cloud information.
  15 in total

1.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.

Authors:  Isabelle C Van Gelder; Vincent E Hagens; Hans A Bosker; J Herre Kingma; Otto Kamp; Tsjerk Kingma; Salah A Said; Julius I Darmanata; Alphons J M Timmermans; Jan G P Tijssen; Harry J G M Crijns
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

2.  Quality of life and outcomes after radiofrequency His-bundle catheter ablation and permanent pacemaker implantation: impact of treatment in paroxysmal and established atrial fibrillation.

Authors:  A P Fitzpatrick; H D Kourouyan; A Siu; R J Lee; M D Lesh; L M Epstein; J C Griffin; M M Scheinman
Journal:  Am Heart J       Date:  1996-03       Impact factor: 4.749

3.  Efficacy and safety of digoxin alone and in combination with low-dose diltiazem or betaxolol to control ventricular rate in chronic atrial fibrillation.

Authors:  K K Koh; K S Kwon; H B Park; S H Baik; S J Park; K H Lee; E J Kim; S H Kim; S K Cho; S S Kim
Journal:  Am J Cardiol       Date:  1995-01-01       Impact factor: 2.778

4.  Prospective, randomized study of atrioventricular ablation and mode-switching, dual chamber pacemaker implantation versus medical therapy in drug-resistant paroxysmal atrial fibrillation. The PAF study. Paroxysmal Atrial Fibrillation.

Authors:  M Brignole; L Gianfranchi; C Menozzi; P Alboni; G Musso; M G Bongiorni; M Gasparini; A Raviele; G Lolli; N Paparella; S Acquarone
Journal:  Europace       Date:  1999-01       Impact factor: 5.214

5.  Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens.

Authors:  R Farshi; D Kistner; J S Sarma; J A Longmate; B N Singh
Journal:  J Am Coll Cardiol       Date:  1999-02       Impact factor: 24.094

6.  Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction.

Authors:  Michael O Sweeney; Anne S Hellkamp; Kenneth A Ellenbogen; Arnold J Greenspon; Roger A Freedman; Kerry L Lee; Gervasio A Lamas
Journal:  Circulation       Date:  2003-06-02       Impact factor: 29.690

7.  Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial.

Authors:  Bruce L Wilkoff; James R Cook; Andrew E Epstein; H Leon Greene; Alfred P Hallstrom; Henry Hsia; Steven P Kutalek; Arjun Sharma
Journal:  JAMA       Date:  2002-12-25       Impact factor: 56.272

8.  Efficacy of oral diltiazem to control ventricular response in chronic atrial fibrillation at rest and during exercise.

Authors:  J S Steinberg; R J Katz; G B Bren; L A Buff; P J Varghese
Journal:  J Am Coll Cardiol       Date:  1987-02       Impact factor: 24.094

9.  Effect of catheter ablation of the atrioventricular junction on quality of life and exercise tolerance in paroxysmal atrial fibrillation.

Authors:  G N Kay; R S Bubien; A E Epstein; V J Plumb
Journal:  Am J Cardiol       Date:  1988-10-01       Impact factor: 2.778

10.  The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation.

Authors:  Brian Olshansky; Lynda E Rosenfeld; Alberta L Warner; Allen J Solomon; Gearoid O'Neill; Arjun Sharma; Edward Platia; Gregory K Feld; Toshio Akiyama; Michael A Brodsky; H Leon Greene
Journal:  J Am Coll Cardiol       Date:  2004-04-07       Impact factor: 24.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.